Abstract PS3-11-09: Alignment between commonly measured and patient-elicited toxicities and impacts of human epidermal growth factor receptor 2-positive (HER2+) breast cancer therapies
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: J. Gable, M. Wraight, K. Roat, E. Kim, R. Nair, J. Buzaglo
Institutions: Jazz Pharmaceuticals (United States), IQVIA (United States)
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7129644831
Cites:
Cited by:
Related to: